Device Trial Radar · NCT05983575
A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
220
Planned (sponsor's estimate)
Start
Oct 31, 2023
Primary completion
Jun 30, 2026
Study completion Mar 31, 2027
Sponsor
- Lead sponsor
- Sound Wave Innovation CO., LTD.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 9, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 50 years, up to 89 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a multicenter, randomized, double-blinded, placebo-controlled Phase 3 study comparing LIPUS-Brain transcranial low-intensity pulsed-wave ultrasound device to placebo in patients with Early Alzheimer's Disease. The primary objective of the study is to assess changes in ADAS-J-cog-14 scores from baseline to 72 weeks.
Conditions
- Alzheimer Disease, Early Onset
Interventions
LIPUS-BrainDevice
Transcranial low-power pulsed-wave ultrasound device
PlaceboDevice
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes in ADAS-J-cog-14 scores from baseline to Week 72Time frame: Performed at Week 72
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Nagoya University Hospital
Nagoya, Aichi-ken, Japan
National Center for Geriatrics and Gerontology
Ōbu, Aichi-ken, Japan
IUHW Narita Hospital
Narita, Chiba, Japan
16 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.